Paolo Manca

1.8k total citations · 1 hit paper
53 papers, 566 citations indexed

About

Paolo Manca is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Paolo Manca has authored 53 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Paolo Manca's work include Colorectal Cancer Treatments and Studies (12 papers), Cancer Genomics and Diagnostics (9 papers) and Genetic factors in colorectal cancer (8 papers). Paolo Manca is often cited by papers focused on Colorectal Cancer Treatments and Studies (12 papers), Cancer Genomics and Diagnostics (9 papers) and Genetic factors in colorectal cancer (8 papers). Paolo Manca collaborates with scholars based in Italy, United States and Spain. Paolo Manca's co-authors include Vittorio Farina, Marco Zedda, Valentina Chisu, Patrick Pauwels, Antonio Russo, Christian Rolfo, Filippo Pietrantonio, Simona Taverna, María José Serrano and Sergio Domenico Gadau and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Clinical Cancer Research.

In The Last Decade

Paolo Manca

47 papers receiving 557 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers

2025 13 citations Margherita Ambrosini, Paolo Manca et al. Nature Reviews Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paolo Manca Italy	14	220	214	189	158	64	53	566
William Cross United Kingdom	11	121 0.6×	191 0.9×	191 1.0×	70 0.4×	63 1.0×	22	454
Meghan L. Rudd United States	10	171 0.8×	221 1.0×	533 2.8×	118 0.7×	124 1.9×	12	878
Beatriz Walter United States	15	123 0.6×	296 1.4×	357 1.9×	124 0.8×	39 0.6×	21	717
Eli S. Williams United States	17	235 1.1×	125 0.6×	442 2.3×	81 0.5×	57 0.9×	40	777
Valentina Foglizzo Italy	12	107 0.5×	260 1.2×	487 2.6×	101 0.6×	110 1.7×	13	718
Anna Ruiz Spain	17	323 1.5×	331 1.5×	499 2.6×	110 0.7×	42 0.7×	34	872
Stefan Steurer Germany	14	90 0.4×	157 0.7×	292 1.5×	269 1.7×	31 0.5×	28	527
G. de Gregorio Italy	12	141 0.6×	96 0.4×	387 2.0×	71 0.4×	33 0.5×	27	624
Sara Franceschi Italy	14	102 0.5×	119 0.6×	236 1.2×	105 0.7×	20 0.3×	35	521
Andreas Voß Germany	12	141 0.6×	110 0.5×	222 1.2×	56 0.4×	113 1.8×	33	587

Countries citing papers authored by Paolo Manca

Since Specialization

Citations

This map shows the geographic impact of Paolo Manca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Manca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Manca more than expected).

Fields of papers citing papers by Paolo Manca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Manca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Manca. The network helps show where Paolo Manca may publish in the future.

Co-authorship network of co-authors of Paolo Manca

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Manca. A scholar is included among the top collaborators of Paolo Manca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Manca. Paolo Manca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Williams, Christopher J.M., et al.. (2025). Targeting the MAP Kinase Pathway in Colorectal Cancer: A Journey in Personalized Medicine. Clinical Cancer Research. 31(13). 2565–2572. 1 indexed citations

Murgioni, Sabina, Maria Bencivenga, Daniele Lavacchi, et al.. (2025). 2141P Real world-data on neoadjuvant/definitive immunotherapy (IO) or chemo-immunotherapy (CT-IO) in patients (pts) with deficient mismatch repair/microsatellite instability-high (dMMR/MSI-H) resectable or potentially resectable gastric/gastroesophageal junction (GEJ) carcinoma. Annals of Oncology. 36. S1123–S1123.

Manca, Paolo, Chin‐Tung Chen, Christina Y. Lee, et al.. (2025). Ultrasensitive ctDNA monitoring for organ preservation in patients with locally advanced rectal cancer. npj Precision Oncology. 10(1). 8–8.

Ambrosini, Margherita, et al.. (2025). Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers. Nature Reviews Clinical Oncology. 22(6). 385–407. 13 indexed citations breakdown →

Nuzzi, Vincenzo, Paolo Manca, Cristina Madaudo, et al.. (2024). SGLT2 inhibitor therapy in patients with advanced heart failure and reduced ejection fraction. Current Problems in Cardiology. 49(11). 102823–102823. 2 indexed citations

Keane, Fergus, Henry Walch, Joanne F. Chou, et al.. (2024). Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal Cancer. Clinical Cancer Research. 30(12). 2672–2683. 5 indexed citations

Gui, Chengcheng, Henry Walch, Ahmet Turan Ilıca, et al.. (2024). Clinicogenomic predictors of survival and intracranial progression after stereotactic radiosurgery for colorectal cancer brain metastases. Journal of neurosurgery. 142(2). 1–11.

Pietrantonio, Filippo, Federica Morano, Monica Niger, et al.. (2024). The Prostaglandin EP4 Antagonist Vorbipiprant Combined with PD-1 Blockade for Refractory Microsatellite-Stable Metastatic Colorectal Cancer: A Phase Ib/IIa Trial. Clinical Cancer Research. 31(4). 649–658. 2 indexed citations

Manca, Paolo, Francesca Corti, Rossana Intini, et al.. (2023). Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors. European Journal of Cancer. 187. 15–24. 26 indexed citations

10.

Pietrantonio, Filippo, Paolo Manca, Sara E. Bellomo, et al.. (2022). HER2 Copy Number and Resistance Mechanisms in Patients with HER2-positive Advanced Gastric Cancer Receiving Initial Trastuzumab-based Therapy in JACOB Trial. Clinical Cancer Research. 29(3). 571–580. 15 indexed citations

11.

Moretto, Roberto, Daniele Rossini, Iolanda Capone, et al.. (2021). Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients. Clinical Colorectal Cancer. 20(4). 314–317. 12 indexed citations

12.

Randon, Giovanni, Rossana Intini, Chiara Cremolini, et al.. (2021). Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer. European Journal of Cancer. 161. 90–98. 15 indexed citations

13.

Torchio, Martina, Francesca Corti, Paolo Manca, et al.. (2020). 1182P Baseline neutrophil-lymphocyte ratio and its variations after adjuvant radiotherapy predict clinical survival outcomes in locally advanced Merkel cell carcinoma (MCC). Annals of Oncology. 31. S781–S781. 1 indexed citations

14.

Rolfo, Christian, Paolo Manca, Roberto Salgado, et al.. (2018). Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer. ESMO Open. 3(5). e000398–e000398. 63 indexed citations

15.

Passiglia, Francesco, Christian Caglevic, Elisa Giovannetti, et al.. (2018). Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment. Seminars in Cancer Biology. 52(Pt 2). 259–268. 10 indexed citations

16.

Reclusa, Pablo, Simona Taverna, Marzia Pucci, et al.. (2017). Exosomes as diagnostic and predictive biomarkers in lung cancer. Journal of Thoracic Disease. 9(S13). S1373–S1382. 90 indexed citations

17.

Manca, Paolo, Francesco Pantano, Michele Iuliani, et al.. (2017). Determinants of bone specific metastasis in prostate cancer. Critical Reviews in Oncology/Hematology. 112. 59–66. 16 indexed citations

18.

Manca, Paolo, M. A. Caría, Juan Blasi, Mireia Martín‐Satué, & O. Mameli. (2012). Cytochrome P450 17α-hydroxylase/C(17,20)-lyase immunoreactivity and molecular expression in the cerebellar nuclei of adult male rats. Journal of Chemical Neuroanatomy. 45(1-2). 18–25. 8 indexed citations

19.

Zedda, Marco, et al.. (2008). Comparative Bone Histology of Adult Horses (Equus caballus) and Cows (Bos taurus). Anatomia Histologia Embryologia. 37(6). 442–445. 32 indexed citations

20.

Zedda, Marco, Paolo Manca, Valentina Chisu, et al.. (2006). Ancient Pompeian Dogs – Morphological and Morphometric Evidence for Different Canine Populations. Anatomia Histologia Embryologia. 35(5). 319–324. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact